510(k) Report

510(k) · Cleared

Cleared

NC TREK NEO Coronary Dilatation Catheter

K220634510(k) TraditionalCleared Jun 30, 2022118-day reviewClass II21 CFR 870.5100

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Abbott Vascular · LOX Catheters, Transluminal Coronary Angioplasty, Percutaneous

Cleared on Jun 30, 2022 as substantially equivalent to K180040 (Abbott Vascular, 2018) after a 118-day review. Its family tree reaches back 2 generations to 2010. 2 of the 9 devices in its family, counting itself, have a Class I recall.

Decided
Jun 30, 2022
Review
118 days
Class
Class II
Product code
LOX
Recalls
None
Predicates
1

Its longest line of descent runs back 2 generations to K103153 (2010). 8 ancestors in all. No later device cites it as a predicate yet. 2 of the 9 devices in this family, counting this one, have a Class I recall.

  1. Root · 2 generations backK103153 Voyager NC Coronary Dilatation Catheter and NC Trek RX Coronary…Abbott Vascular-Cardiac Therapies · 2010 · Recalled (Class I)
  2. 1 generation backK180040 NC TREK™ RX Coronary Dilatation Catheter; NC TREK™ OTW Coronary…Abbott Vascular · 2018
  3. This deviceK220634 NC TREK NEO Coronary Dilatation CatheterAbbott Vascular · 2022

Class I recalls in this family

View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−2K103153Voyager NC Coronary Dilatation Catheter and NC Trek RX Coronary Dilatation…Abbott Vascular-Cardiac Therapies2010Class I
−1K180040NC TREK™ RX Coronary Dilatation Catheter; NC TREK™ OTW Coronary Dilatation…Abbott Vascular2018—
0 (this device)K220634NC TREK NEO Coronary Dilatation CatheterAbbott Vascular2022—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
201131
201220
201310
FIG. 1 — Lineage of K220634, 2010–2022Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

2 devices in this family have a Class I recall. A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new LOX device

  1. #1 K254022 FLASH Flex™ Aorto-Ostial Angioplasty Systemscore 12.3 · 5 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K180040NC TREK™ RX Coronary Dilatation Catheter; NC TREK™ OTW Coronary Dilatation Catheter…
Summary page 4
…PTCA Catheter, LOX, Class II NAME 10. PREDICATE DEVICE NAME NC TREK™ RX Coronary Dilatation Catheter (K180040) 11. REFERENCE DEVICE NAME Voyager NC (P810046/S226, approved August 21,…
Abbott Vascular2018—
†P810046Simpson-Robert Coronary Balloon Dilatation CatheteAdvanced Cardiovascular Systems, Inc.19824
†K103153Voyager NC Coronary Dilatation Catheter and NC Trek RX Coronary Dilatation CatheterAbbott Vascular-Cardiac Therapies2010Class I
†K141236NC Emerge Ptca Dilatation Catheter (Monorail), NC Emerge Ptca Dilatation Catheter…Boston Scientific Corporation20141

Also cleared against K180040: 1 other device →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (2 Class I)

No FDA recall names this device.

Relatives with a Class I recall

Class I is FDA’s most serious recall class. A recall in the family tree is context for this device, not evidence about it.

  • K110134NC Trek RX Coronary Dilatation CatheterAbbott Vascular-Cardiac Therapies · 2011 · 2 generations back · ◆ in the 2011 ancestors bar of FIG. 117 Class I recalls
  • K103153Voyager NC Coronary Dilatation Catheter and NC Trek RX Coronary Dilatation CatheterAbbott Vascular-Cardiac Therapies · 2010 · 2 generations back · ◆ on the line of descent in FIG. 120 Class I recalls

What does this lineage say?

  • The line of descent spans 12 years and passes through 2 companies; a new generation was cleared every 7.6 years on median.
  • 2 of the 8 ancestors have a recall of any class; 2 have a Class I recall.
  • 1 other device also cites its predicate K180040.

How does its category compare?

All LOX devices

LOX Catheters, Transluminal Coronary Angioplasty, Percutaneous: FDA decisions, review times, recalls and adverse event reports over 20 years. 2022, this device’s year, is highlighted.

FDA decisions per year · LOX

4in 2024

2007: 192008: 222009: 282010: 322011: 92012: 102013: 62014: 62015: 42016: 92017: 62018: 72019: 12020: 12021: 62022: 52023: 42024: 42026 (partial year): 6
2007high 32 (2010) · low 0 (2025)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · LOX

241in 2024

2011: 103 days median2012: 120 days median2013: 123 days median2014: 166 days median2015: 119 days median2016: 116 days median2017: 113 days median2018: 80 days median2021: 167 days median2022: 121 days median2023: 138 days median2024: 241 days median2026 (partial year): 156 days median
2007high 241 (2024) · low 80 (2018)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · LOX

4in 2019

2007: 12008: 802019: 4
2007high 80 (2008) · low 0 (2009)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · LOX

1,890in 2025

2007: 1,0532008: 1,0632009: 1,3532010: 1,3922011: 2,0902012: 2,0922013: 2,4362014: 2,3162015: 2,0602016: 2,5782017: 2,7532018: 2,2252019: 2,1022020: 1,9742021: 1,7382022: 1,8162023: 1,7202024: 1,8042025: 1,890
2007high 2,753 (2017) · low 1,053 (2007)2025

MAUDE reports naming product code LOX, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
200719—11,053
200822—801,063
200928—01,353
201032—01,392
2011910302,090
20121012002,092
2013612302,436
2014616602,316
2015411902,060
2016911602,578
2017611302,753
201878002,225
20191—42,102
20201—01,974
2021616701,738
2022512101,816
2023413801,720
2024424101,804
20250—01,890
202661560—

What is it indicated for?

The NC TREK NEO™ Coronary Dilatation Catheters are indicated for:

a) Balloon dilatation of the stenotic portion of a coronary artery or bypass graft stenosis, for the purpose of improving myocardial perfusion

b) Balloon dilatation of a coronary artery occlusion, for the purpose of restoring coronary flow in patients with ST-segment elevation myocardial infarction

c) Balloon dilatation of a stent after implantation (balloon models 2.00 mm — 5.00 mm only)

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K220634: NC TREK NEO Coronary Dilatation Catheter.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K220634

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026